Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker (Ab92547)

Vimentin, VIM

反应种属:Human, Mouse, Rat, Monkey
抗原名称:VIM
应用:WB, IHC, FCM, IF/ICC, MIHC

用户验证的应用

推荐稀释比例

  • IHC-P1/200 - 1/500 Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
  • WB1/1000 - 1/5000
  • ICC/IF2 µg/mL This product gave a positive signal in HeLa (VIM knockout HeLa cells were used as a negative control) fixed with 4% formaldehyde (10 min) and 100% methanol (5 min).
  • Flow Cyt (Intra)1/50 - 1/500 ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.

详细信息

免疫原The exact immunogen used to generate this antibody is proprietary information.
宿主/亚型Rabbit / IgG
抗体类型Monoclonal
全称Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker
产品形式Liquid
储存缓冲液pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
储存条件运输条件: Conditional Ambient 推荐的短期储存时间: 1-2 weeks 推荐的短期储存条件: +4°C 推荐的长期储存条件: -20°C 储存信息: Avoid freeze / thaw cycle
纯化方式Affinity purification Protein A

背景信息

Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker (ab92547) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P, WB and mIHC. Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker (ab92547) was first used in a scientific publication in 1976 and has been cited over 1733 times in peer reviewed journals. It's performance in IHC, Western Blot and immunofluorescence in human and mouse samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker (ab92547) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker (ab92547) has been confirmed by Western Blot testing in Vimentin knockout A549 cells ( ab288984 ). Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker (ab92547) has 91 independent reviews from customers. Vimentin antibodies are often used as loading controls in Western Blot. Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker has been verified in Western Blot samples and detects a band at 54kDa Molecular weight. Anti-Vimentin antibody [EPR3776] - Cytoskeleton Marker (ab92547) specifically detects Vimentin (UniProt ID: P08670; Molecular weight: 54kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EPR3776 - ab193555. Antibody clone EPR3776 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor ® 594, Alexa Fluor ® 488, HRP, Alexa Fluor ® 647, Alexa Fluor ® 568, Alexa Fluor ® 555, PE, Alexa Fluor ® 405, APC, Alexa Fluor ® 750 ( ab154207, ab185030, ab194718, ab194719, ab202504, ab203428, ab209446, ab210152, ab314250, ab321763 ). Vimentin is a protein that supports the structural integrity of cells and is often upregulated in cancer cells, contributing to their aggressive behaviour. It plays a role in cancer progression and metastasis, helping tumors evade the immune system. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.

文献引用 (2179)

Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest.

肿瘤浸润细菌会破坏癌细胞上皮细胞之间的相互作用,并诱导细胞周期停滞。

Fibroblasts of disparate developmental origins harbor anatomically variant scarring potential.

不同发育起源的成纤维细胞具有解剖学上不同的瘢痕形成潜能。

From Fiber Architecture to Functional Attachment: A Clinically Relevant, Mechanically Tunable Cardiac Patch.

从纤维结构到功能性连接:一种具有临床意义、机械可调的心脏补片。

Braig Johannes, Kent Ross, Goienetxe Ainitze Gereka, Laita Nicolás, Wu Ming, Martínez Miguel Ángel, Serra Margarida, Janssens Koen, Urtaza Uzuri, Larequi Eduardo, Anaut-Lusar Ilazki, Gillijns Hilde, Algoet Michiel, van Kerkhof Britt, van der Knaap Maite, Cedillo-Servin Gerardo, Castilho Miguel, van Mil Alain, Sluijter Joost P G, Malda Jos, Claus Piet, Bovendeerd Peter H M, Peña Estefanía, Doblare Manuel, Oosterlinck Wouter, Janssens Stefan, Zaldua Ane M, Iglesias-García Olalla, Prósper Felipe, Vega Manuel M Mazo, Groll Jürgen, Jüngst Tomasz

Ameliorating post-infarction myocardial fibrosis and cardiac function via ROS-responsive hydrogel-mediated IL-11 antibody delivery.

通过 ROS 响应性水凝胶介导的 IL-11 抗体递送改善心肌梗死后心肌纤维化和心脏功能。

You Ting, Zhang Yong, Su Haotao, Wang Na, Zhang Xinkui, Anwaier Sainiwaier, Long Xiang, Han Linjiang, Wu Yeting, Liang Jialiang, Yang Yanzhen, Yu Changjiang, Chen Zerui, Liu Jian, Sun Tucheng, Huang Huanlei, Zhu Shuoji, Liu Nanbo, Zhu Ping, Chen Jimei, Zhuang Jian, Wang Lu, Yan Xinjian

Versatile Microfluidics Platform for Enhanced Multitarget Super-Resolution Microscopy.

用于增强多目标超分辨率显微镜的多功能微流控平台。

Basak Samrat, Vu Kim-Chi, Mougios Nikolaos, Oleksiievets Nazar, Pollack Yoav G, Brandenburg Sören, Opazo Felipe, Lehnart Stephan E, Enderlein Jörg, Tsukanov Roman

VAMP7-dependent late endosomal secretion of ER and mitochondrial proteins impacts the tumor microenvironment and macrophage engagement.

VAMP7 依赖的内质网和线粒体蛋白的晚期内体分泌会影响肿瘤微环境和巨噬细胞的参与。

Vats Somya, Dionisio Pedro, Lemercier Quentin, Pineau Raphael, Therreau Ludivine, Lipecka Joanna, Cholley Béatrice, Moog Jean-Baptiste, Wojnacki Jose, Keime Céline, Zala Diana, Bun Philippe, Freire Sofia, Domingues Neuza, Danglot Lydia, Guerrera Ida Chiara, Delevoye Cédric, Chevet Eric, Raimundo Nuno, Galli Thierry

Injured epithelial cell states impact kidney allograft survival after T-cell-mediated rejection.

受损的上皮细胞状态会影响T细胞介导的排斥反应后肾脏同种异体移植的存活率。

Pfefferkorn Anna Maria, Jahn Lorenz, Gauthier Patrick T, Kulow Vera Anna, Roeles Johannes, Müller-Bötticher Niklas, Gerhardt Louisa M S, Leiz Janna, Sarfraz Sadia, Plumbom Izabela, Greite Robert, Lovric Svjetlana, Gamrekelashvili Jaba, Limbourg Florian, Schmitz Jessica, Bräsen Jan Hinrich, Scheffner Irina, Sauer Igor M, Aigner Felix, Altmüller Janine, Conrad Thomas, Gwinner Wilfried, Ishaque Naveed, Fähling Michael, Schmidt-Ott Kai M, Halloran Philip F, Ashraf Muhammad Imtiaz, Hinze Christian

Micro-Organ Chip Deciphers Tumor-Derived G-CSF as Remote Commander of Lung Pre-Metastatic Niche via VEGFA-KDR Cascade.

微型器官芯片揭示肿瘤来源的 G-CSF 通过 VEGFA-KDR 级联反应远程调控肺部转移前微环境。

Zhang Jingxin, Huang Xiaoying, Ma Lingchuan, Chen Zixing, Li Tianyao, Wang Lijian, Guo Yutong, Xu Hu, Li Junqi, Qin Jiang-Jiang, Wang Xiang, Cao Yuhong, Miao Kai

Injured cardiac targeting magnetic nanovesicles for mRNA treatment of myocardial infarction.

靶向受损心脏的磁性纳米囊泡用于治疗心肌梗死的mRNA疗法。

JAM-C prevents ocular fibrosis by suppressing the TAZ/KLF6 pathway.

JAM-C 通过抑制 TAZ/KLF6 通路来预防眼纤维化。

Chen Min, Li Wanhong, Du Yuxiang, Zhao Yuanlong, Guo Ying, Li Ying, Wang Xiaolu, Huang Lijuan, Zeng Xiaoling, Zhang Yihan, Huang Guanqun, Wang Shasha, Kuang Haiqing, Sun Guangli, Jiang Qin, Li Xuri, Lu Weisi
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 218